Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00665327 · ClinicalTrials.gov registry record · Phase 4
Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia
A Phase 4 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 4
- Development phase
- 401
- Enrollment target
NCT00665327: Completed Phase 4 study, sponsored by Bayer.
NCT00665327 is a Phase 4 study that has completed, run by Bayer. The registered enrollment target is 401 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00665327, a Phase 4 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 401 participants
- Enrollment target
Study Summary
This study was to assess the safety of sequential intravenous (IV)/oral (PO) moxifloxacin (Avelox®) compared with sequential IV/PO levofloxacin (Levaquin®) in the treatment of elderly subjects (aged \≥ 65 years) with community-acquired pneumonia (CAP) who required initial IV therapy. This study also included an assessment of the clinical and bacteriologic effectiveness of both drugs.
Interventions
- DRUG Levofloxacin
- DRUG Avelox (Moxifloxacin, BAY12-8039)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2002-11 |
| Est. Completion | 2004-04 |
| Phase | Phase 4 |
What the finished NCT00665327 record still lists
NCT00665327 is an interventional study that assigns participants to a tested intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 2 interventions - of which Levofloxacin is the first listed.
NCT00665327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00665327 about?
NCT00665327 is a clinical study titled "Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia". This study was to assess the safety of sequential intravenous (IV)/oral (PO) moxifloxacin (Avelox®) compared with sequential IV/PO levofloxacin (Levaquin®) in the treatment of elderly subjects (aged \≥ 65 years) with community-acquired pneumonia (CAP) who required initial IV therapy. This stud...
What is the current status of trial NCT00665327?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 401 participants. The study started on 2002-11. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00665327?
The interventions under investigation include: Levofloxacin (DRUG), Avelox (Moxifloxacin, BAY12-8039) (DRUG).
Who is sponsoring clinical trial NCT00665327?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00665327's enrollment target sits among peer trials
401 210th of 2000 higher than 1,790 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia